Dynamic scheduling of the upcoming screening exam based on screening history and other parameters
根据筛选历史和其他参数动态安排即将进行的筛选检查
基本信息
- 批准号:9810977
- 负责人:
- 金额:$ 43.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeChronic DiseaseClinicalComputer softwareDiagnosisDiseaseEarly DiagnosisFemaleFoundationsFrequenciesFutureGenderGoalsIncidenceIndividualKnowledgeLeadLikelihood FunctionsLungMalignant NeoplasmsMalignant neoplasm of lungMethodsModalityModelingMotivationOutputPatientsPersonsPhysiciansPlug-inPolicy MakerProbabilityProstate, Lung, Colorectal, and Ovarian Cancer Screening TrialPulmonary MassRecording of previous eventsResearchRiskRisk FactorsRoentgen RaysScheduleScreening ResultScreening for cancerSmokerSmoking StatusSpiral Computed TomographyStatistical MethodsTechniquesTestingThoracic RadiographyTimeValidationX-Ray Computed Tomographybasecohortdensitylow-dose spiral CTlung cancer screeningmalenever smokerpre-clinicalscreeningsimulationsoftware developmenttime intervaltrial designtv watchinguser friendly software
项目摘要
Project Summary:
Motivated by the need of physicians and patients to make informed decision, probability methods are proposed
to address the problem of when to schedule the next exam for an asymptomatic individual with a history of
negative screenings. The method provides a screening time interval to limit the risk of being a clinical incident
case to a small value, such as 5% or 10%. The time interval is a function of the three key parameters (i.e.,
screening sensitivity, sojourn time in preclinical state and transition time distribution in disease-free state), a
person's current age/gender, smoking status, and one's screening history. Distribution of Lead time (ie.
diagnosis time advanced by screening) and probability of over-diagnosis are derived, if one would be
diagnosed with cancer at the future scheduled time. A new likelihood function to estimate the three key
parameters are proposed and will be validated to increase the accuracy of the estimation. The methods will be
applied to four cohorts from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial for lung cancer
(PLCO-Lung) and four cohorts from the National Lung Screening Trials (NLST). The specific aims are:
1. To estimate the three key parameters using a new likelihood function in the eight cohorts using either chest
X-ray or Low Dose Computed Tomography (CT). Eight cohorts (four from PLCO-Lung using X-ray:
male/female smokers, male/female never-smokers; four from NLST: male/female smokers via X-ray,
male/female smokers via CT) were identified. The three key parameters will be estimated when sensitivity
is modeled as a function of the sojourn time and time spent in the preclinical state using our new likelihood
method. This lays a foundation for predictions and estimations in Aim 2, since the future time interval is a
function of the three key parameters; and we will plug in estimates of the three key parameters in Aim 2 to
obtain the optimal screening time.
2. To schedule the next screening exam dynamically for an asymptomatic individual with any screening
history. A new method using conditional probability of incidence before the next exam is proposed. The
next screening time is found by limiting this probability to a small value, to guarantee early detection and
control the risk of over-diagnosis. The lead-time distribution and the probability of over-diagnosis are
derived, if one would be diagnosed with cancer at the next proposed screening time, so that predictive
information can be provided to individuals on how early his/her disease could be detected, and the risk of
over-diagnosis if one undergoes screening exams as suggested.
3. To develop a user-friendly software for Aims 1 and 2, and made available to the public.
In summary policy makers can use information from this research to recommend future screening frequencies
for different risk groups (e.g., age, gender, smoking status) under different screening techniques (X-ray or CT).
Physicians may use results from Aim 3 (the developed software) to schedule the next exam for individuals.
项目概要:
基于医生和患者做出知情决策的需要,提出了概率方法
为了解决何时为具有以下病史的无症状个体安排下一次检查的问题,
消极的筛选该方法提供了筛选时间间隔,以限制成为临床事件的风险
case的值,例如5%或10%。时间间隔是三个关键参数的函数(即,
筛选灵敏度、在临床前状态的逗留时间和在无病状态的过渡时间分布),
一个人的当前年龄/性别,吸烟状况和一个人的筛查史。交付周期(Lead Time)
诊断时间提前筛选)和过度诊断的概率,如果一个将是
在未来的预定时间被诊断出患有癌症。一种新的似然函数估计三个关键
参数的建议,并将进行验证,以提高估计的准确性。方法将是
应用于前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验的四个队列,
(PLCO-Lung)和来自国家肺筛查试验(NLST)的四个队列。具体目标是:
1.使用新的似然函数估计8个队列中的3个关键参数,
X射线或低剂量计算机断层扫描(CT)。8个队列(4个来自使用X线的PLCO-肺:
男性/女性吸烟者,男性/女性从不吸烟者; NLST中的4例:男性/女性吸烟者(通过X光检查),
男性/女性吸烟者(通过CT)。当灵敏度为100%时,将估计三个关键参数。
使用我们新的可能性,将其建模为逗留时间和在临床前状态下花费的时间的函数
法这为目标2中的预测和估计奠定了基础,因为未来的时间间隔是一个
函数;我们将在目标2中插入三个关键参数的估计值,
获得最佳筛选时间。
2.为无症状个体动态安排下一次筛查,
历史提出了一种在下次考试前使用条件概率的新方法。的
通过将该概率限制为小值来找到下一个筛选时间,以保证早期检测,
控制过度诊断的风险。提前期分布和过度诊断的概率是
如果一个人在下一个建议的筛查时间被诊断出患有癌症,
可以向个人提供关于他/她的疾病可以多早被检测到以及
过度诊断,如果一个人按照建议进行筛查检查。
3.为目标1和2开发一个方便用户的软件,并向公众提供。
总之,政策制定者可以利用这项研究的信息来推荐未来的筛查频率。
对于不同的风险组(例如,年龄、性别、吸烟状况)在不同的筛查技术(X射线或CT)下进行。
医生可以使用Aim 3(开发的软件)的结果来安排个人的下一次检查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dongfeng Wu其他文献
Dongfeng Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dongfeng Wu', 18)}}的其他基金
Statistical Inference for Lead Time in Cancer Screening
癌症筛查提前期的统计推断
- 批准号:
6938206 - 财政年份:2005
- 资助金额:
$ 43.53万 - 项目类别:
Statistical Inference for Lead Time in Cancer Screening
癌症筛查提前期的统计推断
- 批准号:
7047845 - 财政年份:2005
- 资助金额:
$ 43.53万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 43.53万 - 项目类别:
Directed Grant